6.39BMarket Cap45.40P/E (TTM)
31.370High30.470Low3.05MVolume30.800Open31.000Pre Close94.19MTurnover3.24%Turnover Ratio83.43P/E (Static)206.97MShares33.64052wk High2.49P/B2.90BFloat Cap12.34052wk Low--Dividend TTM94.07MShs Float33.640Historical High--Div YieldTTM2.90%Amplitude8.750Historical Low30.867Avg Price1Lot Size
Life Time Stock Forum
Select biotech/pharma names showing strength following ESMO:
$Clovis Oncology (CLVS.US)$ +11.3%, $Cardiff Oncology (CRDF.US)$ +9%, $Immatics (IMTX.US)$ +8.3%, $IDEAYA Biosciences (IDYA.US)$ +8%, $Lyra Therapeutics (LYRA.US)$ +5.7%, $POINT Biopharma (PNT.US)$ +5.7%, $Edgewise Therapeutics (EWTX.US)$ +4.7%, $Concert Pharmaceuticals (CNCE.US)$ +3.6%, $Deciphera Pharmaceuticals (DCPH.US)$ +3.2%, $Veracyte (VCYT.US)$ +2.6%, $SpringWorks Therapeutics (SWTX.US)$ +2.3%, ...
No comment yet